Navigation Links
Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
Date:10/5/2007

-- conference call and audio web cast on October 9, 2007 --

BELLEVILLE, ON, Oct. 5 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company (TSX:BNC), will be discussing the U.S. Department of Agriculture (USDA) comment on a field trial for its E. coli O157:H7 cattle vaccine during a:

Conference Call & Audio Web Cast

Tuesday, October 9, 2007

9:00 a.m. (Eastern)

To participate in the teleconference, call 416-644-3414/toll-free 1-800-733-7571.

A listen-only audio web cast will be available at:

http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2039180 (English)

http://www.cnw.ca/fr/webcast/viewEvent.cgi?eventID=2039180 (French)

A replay of the conference call will be available until October 16, 2007 by calling (416) 640-1917 or toll-free 1-877-289-8525 (passcode: 21249516 followed by the number sign).

The web cast will be available for replay using the above links until January 9, 2008.

About Bioniche Life Sciences

Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs approximately 195 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety. The Company's primary goal is to develop proprietary cancer therapies supported by revenues from marketed products in human and animal health. For more information, please visit http://www.Bioniche.com.


'/>"/>
SOURCE Bioniche Life Sciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Indian Minister wanted Media to Propaganda HIV/AIDS awareness
2. Scientist Calls Upon Media To Retract His Work
3. Rabies Requires Immediate Treatment
4. Media Messages Can Serve To Reduce Smoking Indoors
5. Media Plays Crucial Role In Flu Vaccinations
6. Chronic shortage of GPs in Australia, Need for Immediate Intervention
7. Substance Abuse Prevention Messages Better Received Among Teenagers in the Form of Media Campaigns and Curriculum
8. Medias Plays Vital Role In Sexual Behavior Of Teenagers
9. Immediate Attention Is Needed To Tackle the Obesity Crisis among Children
10. Long Term Mediation Not Advisable To Treat Hot Flashes
11. PharmaVentures Exploits Fastest Growing Media Channel to Launch First Pharmaceutical Business Television Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... 2017 , ... An August 3rd article on Reuters covers a new University of ... JAMA (the Journal of the American Medical Association). The study found that a lower percentage ... 30, when compared to patients with lower BMIs. At present, weight loss patients must have ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Data Council, the leading ... was acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the ... industry’s leading suppliers, brokers, distributors and retailers. The Data Council will become a ...
(Date:8/16/2017)... ... August 16, 2017 , ... In ... They celebrate 30 years in business this year, and they’re marking the milestone ... space to serve their patients. , It stands to reason that, given ...
(Date:8/16/2017)... ... August 16, 2017 , ... Modern Consulting Insurance & ... program. Partnering once again with Boys & Girls Clubs of Greater Kansas City, ... area’s very own American Idol. With all proceeds benefitting local worthy causes, donations ...
(Date:8/16/2017)... ... ... Paul Vitenas, MD, FACS , is honored to announce that he ... the nation’s top physicians, in a variety of specialties. This marks the fourth year ... Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted provider of information on ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... , Aug. 2, 2017 ... Who,s Who as a Pinnacle Lifetime Professional in ... Key Account Manager at Turing Pharmaceuticals, AG. Her ... troubleshooting and relationship building.                ... more than 25 years of experience as a ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
Breaking Medicine Technology: